Aspergillosis.
Segal
Brahm H
BH
Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA. brahm.segal@roswellpark.org
D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use*; D001228:Aspergillosis / Q000175:diagnosis / Q000276:immunology / Q000628:therapy; D003131:Combined Modality Therapy; D003646:Debridement; D054714:Echinocandins / Q000627:therapeutic use; D006801:Humans; D007111:Immunity, Cellular; D007113:Immunity, Innate; D008172:Lung Diseases, Fungal / Q000175:diagnosis / Q000628:therapy; D011743:Pyrimidines / Q000627:therapeutic use*; D014230:Triazoles / Q000627:therapeutic use*; D065819:Voriconazole
D000935:Antifungal Agents; D054714:Echinocandins; D011743:Pyrimidines; D014230:Triazoles; D000666:Amphotericin B; D065819:Voriconazole